| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/24/2012 | CA2818612A1 Therapeutic agent formulations for implanted devices |
| 05/24/2012 | CA2818166A1 Keratin compositions for treatment of bone deficiency or injury |
| 05/24/2012 | CA2818097A1 Therapeutic compositions comprising rilpivirine hcl and tenofovir disoproxil fumarate |
| 05/24/2012 | CA2818083A1 Immunogenic compositions |
| 05/24/2012 | CA2817982A1 Controlled release mucoadhesive systems |
| 05/24/2012 | CA2817969A1 Enteric-coated sodium metabisulfite livestock feed additive for vomitoxin detoxification |
| 05/24/2012 | CA2817888A1 Continuous administration of l-dopa, dopa decarboxylase inhibitors, catechol-o-methyl transferase inhibitors and compositions for same |
| 05/24/2012 | CA2817250A1 Novel compositions and uses of anti-hypertension agents for cancer therapy |
| 05/24/2012 | CA2816997A1 Novel polymer derivative of cytidine metabolic antagonist |
| 05/24/2012 | CA2816660A1 Pharmaceutical composition comprising citrate and bicarbonate salts, and use thereof for treating cystinuria |
| 05/24/2012 | CA2815898A1 Transdermal therapeutic system comprising buprenorphine |
| 05/24/2012 | CA2815810A1 Compositions with antibacterial and wound healing activity |
| 05/24/2012 | CA2815044A1 Preparation and use of combination enzyme and gastrointestinal modulator delivery systems |
| 05/23/2012 | EP2455104A1 Bio-functionalized stimulus-responsive dissolvable PEG-hydrogels |
| 05/23/2012 | EP2455084A2 Antihypertensive composition containing a ginsenoside-enriched fraction |
| 05/23/2012 | EP2455083A1 Pharmaceutical composition for dermal use comprising calcipotriol and a corticosteroid |
| 05/23/2012 | EP2455074A1 Topical pharmaceutical compositions of flurbiprofen and methyl salicylate |
| 05/23/2012 | EP2455072A1 Controlled release formulations of octreotide |
| 05/23/2012 | EP2455071A1 Capsule Formulation |
| 05/23/2012 | EP2455070A1 Capsule Formulation |
| 05/23/2012 | EP2455069A1 Non-active administration form, method for producing same and use of same |
| 05/23/2012 | EP2455068A1 Pharmaceutical composition for treating HCV infections |
| 05/23/2012 | EP2455067A1 Directly compressible tricalcium phosphate |
| 05/23/2012 | EP2455066A1 Pharmacological preparation for topical use containing n-palmitoyl-vanillamide |
| 05/23/2012 | EP2455065A1 Modified two-component gelation systems, methods of use and methods of manufacture |
| 05/23/2012 | EP2455064A1 Device for treating a periodontal disease |
| 05/23/2012 | EP2453916A1 Supralingual vaccines and applicators |
| 05/23/2012 | EP2453886A2 Pharmaceutical for oral delivery comprising mgbg and methods of treating disease |
| 05/23/2012 | EP2453881A2 Porous-wall hollow glass microspheres as carriers for biomolecules |
| 05/23/2012 | EP2453880A1 Separating layers for pharmaceutical preparations to prevent interactions between medicinal drugs and pharmaceutical-technological adjuvants |
| 05/23/2012 | EP2453879A2 Pellets formulation |
| 05/23/2012 | EP2453878A1 Material and process for incorporation of low dosage active pharmaceutical ingredients and use thereof |
| 05/23/2012 | EP2453877A1 Sustained-release drug carrier composition |
| 05/23/2012 | EP2453876A1 Hdl comprising a therapeutic agent and use in therapy |
| 05/23/2012 | EP2453875A1 Emulsion activatable by ultrasounds and method for producing same |
| 05/23/2012 | EP2453874A2 Methods for inhibiting yellow color and peroxide formation in a composition |
| 05/23/2012 | EP2453873A1 Improvements in and relating to colon cleansing compositions |
| 05/23/2012 | EP2453872A2 Olopatadine nasal spray regimen for children |
| 05/23/2012 | EP2453871A1 Orally administered bacteria as vehicles for systemic delivery of agents |
| 05/23/2012 | EP2453870A2 Injectable formulations containing asenapine and method of treatment using same |
| 05/23/2012 | EP2453743A1 N-acetyl cysteine compositions and methods to improved the therapeutic efficacy of acetaminophen |
| 05/23/2012 | EP2292230B1 Tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic |
| 05/23/2012 | EP2292229B1 Tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic |
| 05/23/2012 | EP2252271B1 Dip coated compositions containing a starch having a high amylose content |
| 05/23/2012 | EP2081547B1 Galenic form for the trans-mucosal delivery of active ingredients |
| 05/23/2012 | EP1838287B1 Process for preparing granulates comprising amoxicillin |
| 05/23/2012 | EP1806151B1 Drug for external use and adhesive patch |
| 05/23/2012 | EP1778187B1 Compositions forming non-lamellar dispersions |
| 05/23/2012 | EP1761248B1 Carbohydrate-derivatized liposomes for targeting cellular carbohydrate recognition domains of ctl/ctld lectins, and intracellular delivery of therapeutically active compounds |
| 05/23/2012 | EP1755555B1 Methods for preparing dry powder compositions of glycopyrrolate |
| 05/23/2012 | EP1499329B2 Use of xenon for the control of neurological deficits associated with cardiopulmonary bypass |
| 05/23/2012 | EP1465687B2 Cartridge for preparation of an acetate dialysis concentrate from a highly densified concentrate and method of processing the cartridge |
| 05/23/2012 | EP1443900B1 Lipid carrier compositions with enhanced blood stability |
| 05/23/2012 | CN202223586U Traditional Chinese medicine pulp for treating combined gallbladder channel tissue and kidney channel tissue diseases and package thereof |
| 05/23/2012 | CN202223585U Traditional Chinese medicine pulp for treating combined gallbladder channel tissue and liver channel tissue diseases and package thereof |
| 05/23/2012 | CN202223582U Veterinary tablet |
| 05/23/2012 | CN202223581U Spongy preparation releasing structure |
| 05/23/2012 | CN202223414U Cooling gel sheet |
| 05/23/2012 | CN202222409U Preparation without chemical additive |
| 05/23/2012 | CN1939424B Preparation process of Rhizoma corydalis analgetic oral liquid |
| 05/23/2012 | CN1886427B Cellulose interpolymers and method of oxidation |
| 05/23/2012 | CN1840129B Gel for treating gynecological disease and preparation method thereof |
| 05/23/2012 | CN1659288B Pharmaceutical composition for preventing or reducing DNA damage |
| 05/23/2012 | CN1492763B Compositions for delivering bisphosphonates |
| 05/23/2012 | CN102471766A 带有酶的粘性贴片 Sticky patch with enzymes |
| 05/23/2012 | CN102471524A Powdery or granulated composition comprising a copolymer, a salt of a fatty monocarboxylic acid and a fatty monocarboxylic acid and/or a fatty alcohol |
| 05/23/2012 | CN102471331A Solid oral formulations and crystalline forms of inhibitor of apoptosis protein |
| 05/23/2012 | CN102471224A 新型酯及其用途 The new esters and their use |
| 05/23/2012 | CN102470237A Solid drug tablets for implantable drug delivery devices |
| 05/23/2012 | CN102470182A 用于在出血性紊乱的治疗和预防性处理中进行非静脉内施用的白蛋白融合凝血因子 Albumin is used for non-intravenous administration in the treatment of bleeding disorders and the prophylactic treatment of coagulation factor fusion |
| 05/23/2012 | CN102470179A Microneedle array |
| 05/23/2012 | CN102470177A Coating composition |
| 05/23/2012 | CN102470176A 药物制剂 Pharmaceutical preparations |
| 05/23/2012 | CN102470163A Composition for external preparation for skin |
| 05/23/2012 | CN102470147A 适用于血浆的平衡明胶溶液 Gelatin solution applied to the plasma equilibrium |
| 05/23/2012 | CN102470140A 含有人参皂苷浓缩流分的用于降血压的组合物 Containing ginseng saponin fractions concentrate composition for lowering blood pressure |
| 05/23/2012 | CN102470139A Compositions comprising finafloxacin and methods for treating ophthalmic, otic, or nasal infections |
| 05/23/2012 | CN102470134A 药物组合物和固体形式 The pharmaceutical compositions and solid forms |
| 05/23/2012 | CN102470131A 含有芬太尼的外用粘合剂制剂 Topical adhesive formulations containing fentanyl |
| 05/23/2012 | CN102470114A 口臭去除剂 Halitosis remover |
| 05/23/2012 | CN102470113A 包含糖醇的牙周病原菌增殖抑制抗菌剂 Periodontal pathogen proliferation comprising a sugar alcohol, an antibacterial agent |
| 05/23/2012 | CN102470112A 包含阴离子聚合物材料和含6-22个碳原子的饱和单羧酸的盐的组合物 The compositions comprise a salt of an anionic polymeric material containing 6-22 carbon atoms and a saturated monocarboxylic acid of |
| 05/23/2012 | CN102470111A 含充液胶囊的药物片剂 Liquid-filled capsules containing pharmaceutical tablets |
| 05/23/2012 | CN102470110A 包含托特罗定的透皮组合物 Comprising the transdermal composition of tolterodine |
| 05/23/2012 | CN102470109A 3-氰基喹啉片剂制剂及其应用 3-cyano quinoline tablet formulation and its application |
| 05/23/2012 | CN102470108A 非pH依赖型制剂(6-(5-氯-2-吡啶基)-5-[(4-甲基-1-哌嗪基)羰氧基]-7-氧代-6，7-二氢-5H-吡咯并[3，4-b]吡嗪) A non-pH-dependent type preparation (6- (5-chloro-2-pyridinyl) -5 - [(4-methyl-1-piperazinyl) carbonyloxy] -7-oxo-6,7-dihydro- -5H- pyrrolo [3,4-b] pyrazine) |
| 05/23/2012 | CN102470107A 小丸制剂 Pellet formulations |
| 05/23/2012 | CN102470106A Composition comprising oil drops |
| 05/23/2012 | CN102470105A 持续释放药物载体组合物 Sustained release drug carrier composition |
| 05/23/2012 | CN102470104A Pharmaceutical composition including a DHA ester to be parenterally administered |
| 05/23/2012 | CN102470103A 用作丙型肝炎病毒蛋白酶抑制剂的药物组合物 Used as the HCV protease inhibitor pharmaceutical compositions |
| 05/23/2012 | CN102470102A 用于治疗指甲真菌感染的组合物和方法 Compositions and methods for treating fungal infections of the nail |
| 05/23/2012 | CN102470101A 用于儿科应用的药物递送系统(糯米纸囊剂) For pediatric applications, drug delivery systems (wafers) |
| 05/23/2012 | CN102470100A 用于制备并入了有效生物活性分子的微粒的方法 For the preparation of biologically active molecules incorporated into the microparticles effective method |
| 05/23/2012 | CN102470099A Olopatadine nasal spray regimen for children |
| 05/23/2012 | CN102470098A 用于mpi引导的药物递送的刺激-响应性载体 Stimulus for mpi guided drug delivery - Response carrier |
| 05/23/2012 | CN102469809A 包衣制剂 Coating formulation |
| 05/23/2012 | CN102466658A 一种注射剂中5-羟甲基糠醛含量的测定方法 An injection method for the determination of 5-HMF content |
| 05/23/2012 | CN102464874A 星型多臂plga/peg两亲性嵌段共聚物及其应用 Star Dobby plga / peg amphiphilic block copolymer and its application |
| 05/23/2012 | CN102462845A 磁性靶向载体的制备方法、磁性靶向载体药物系统及其使用方法 The magnetically targetable carrier preparation, the magnetically targetable drug carriers using the system and method |